Found 298 articles for: "alopecia"
Clinical Pathologic Mismatch in a TNF-α Inhibitor-Associated Drug Reaction
August 2019 | Volume 18 | Issue 8 | Case Reports | 218 | Copyright © August 2019
A 56-year-old Caucasian male with a history of chronic plaque psoriasis, primary sclerosing cholangitis status-post liver transplant on tacrolimus, and ulcerative colitis on infliximab developed a pro...
Read MorePharmacokinetic Profile, Safety, and Tolerability of Clascoterone (Cortexolone 17-alpha propionate, CB-03-01) Topical Cream, 1% in Subjects With Acne Vulgaris: An Open-Label Phase 2a Study
June 2019 | Volume 18 | Issue 6 | Original Article | 563 | Copyright © June 2019
Clascoterone (cortexolone 17α-propionate, CB-03-01) 1% cream, a topical, androgen receptor (AR) inhibitor under...
Read MoreSorafenib Toxicity Mimicking Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome
May 2019 | Volume 18 | Issue 5 | Case Reports | 468 | Copyright © May 2019
Sorafenib is an oral multikinase inhibitor approved by the United States Food and Drug Administration for the treatment of advanced hepatocellular and renal cell carcinoma. Cases of sorafenib-induced ...
Read MoreNon-Surgical Fat Reduction and Topical Modulation of Adipose Tissue Physiology
April 2019 | Volume 18 | Issue 4 | Original Article | 375 | Copyright © April 2019
Non-surgical fat reduction procedures have gained in popularity over the past few years and remain in great demand. The process results in accumulation of breakdown products, lipid droplets, that are...
Read MoreOver-the-Counter Hair Loss Treatments: Help or Hype?
March 2019 | Volume 18 | Issue 3 | Editorials | 312 | Copyright © March 2019
This review of the current available OTC options is much appreciated in the December 2018 article by Bater and Rieder, however, most of the products mentioned have no current research or data in th...
Read MoreLow Dose Naltrexone in Dermatology
March 2019 | Volume 18 | Issue 3 | Original Article | 235 | Copyright © March 2019
Low-dose naltrexone (LDN) has been successfully studied as an immunomodulatory and anti-inflammatory therapy in a wide ...
Read MoreA Review of the Dermatologic Symptoms of Idiopathic Mast Cell Activation Syndrome
February 2019 | Volume 18 | Issue 2 | Original Article | 162 | Copyright © February 2019
Since the first reported cases in 2007, idiopathic mast cell activation syndrome has been increasingly recognized. Understanding of the cutaneous manifestations of this condition is imperative for der...
Read MoreThe Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review
February 2019 | Volume 18 | Issue 2 | Original Article | 155 | Copyright © February 2019
Introduction: Topical minoxidil is the first-line therapy for treating both male and female androgenetic alopecia. Currently there are no comprehensive reviews on the clinical efficacy of minoxidil on...
Read MoreFinal Data from the Condition of Submental Fullness and Treatment Outcomes Registry (CONTOUR)
January 2019 | Volume 18 | Issue 1 | Original Article | 40 | Copyright © January 2019
Perceptions of attractiveness can be negatively affected by submental fullness. Patients seeking to improve their submental contour have a variety of treatment options including surgical procedures, e...
Read MoreOver-the-Counter Hair Loss Treatments: Help or Hype?
December 2018 | Volume 17 | Issue 12 | Original Article | 1317 | Copyright © December 2018
INTRODUCTION: A limited number of treatments have been approved for androgenetic alopecia, however, myriad over-the-counter products for hair loss are available and readily purchased ...
Read MoreSenior Resident Peer-to-Peer Case StudiesAfter
November 2018 | Volume 17 | Issue 11 | Editorials | 1248 | Copyright © November 2018
The content of these case studies, ideal to review during peer study groups, was developed by Elizabeth Robinson, MD and Jennifer Aronica, MD under the guidance of dermatologist Adam Friedman, MD, FAA...
Read MoreEpidemiology of Skin Diseases in a Diverse Patient Population
October 2018 | Volume 17 | Issue 10 | Original Article | 1032 | Copyright © October 2018
BACKGROUND: Epidemiologic studies of patients who present to dermatology clinics are necessary to identify the needs of patients. OBJECTIVE: To quantify and compare diagnoses according to race, eth...
Read MoreAssessing the Potential Role for Topical Melatonin in an Antiaging Skin Regimen
September 2018 | Volume 17 | Issue 9 | Original Article | 966 | Copyright © September 2018
Background: Melatonin is an endogenous hormone commonly associated with regulation of sleep. However, over the last two decades, research has elucidated a range of effects associated with the compound...
Read MoreAn Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review
August 2018 | Volume 17 | Issue 8 | Features | 914 | Copyright © August 2018
KD is an 8 year-old male patient who presented to our clinic in December 2016 with a history of patchy hair loss for many months duration that was worsening. KD’s past medical history was notable fo...
Read MoreSuccessful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib
July 2018 | Volume 17 | Issue 7 | Case Reports | 800 | Copyright © July 2018
Alopecia areata is an autoimmune disease involving the hair follicle with a chronic, relapsing course. Tofacitinib...
Read MoreWidespread Skin Necrosis Secondary to Gemcitabine Therapy
May 2018 | Volume 17 | Issue 5 | Case Reports | 582 | Copyright © May 2018
Gemcitabine, a pyrimidine nucleoside analogue, is an oncologic agent used in the treatment of cutaneous T-cell lymphoma (CTCL). Common dermatologic reactions associated with gemcitabine include alopec...
Read MoreA Six-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Women With Self-Perceived Thinning Hair
May 2018 | Volume 17 | Issue 5 | Original Article | 558 | Copyright © May 2018
Hair loss is a complex problem that generates significant concern for those who are affected. Patients seeking medical t...
Read MoreVismodegib and the Hedgehog Pathway Inhibitors: A Historical Perspective to Current Clinical Application
May 2018 | Volume 17 | Issue 5 | Original Article | 506 | Copyright © May 2018
Vismodegib (Erivedge, Genentech-Roche) is the first in class of Hedgehog pathway inhibitors approved for treatment of metastatic basal cell carcinoma (BCC), or locally advanced BCC that has recurred a...
Read MoreSuccessful Therapy of Severe Oro-Labial Herpes Simplex With Muco-Adhesive Acyclovir
April 2018 | Volume 17 | Issue 4 | Case Reports | 479 | Copyright © April 2018
Although muco-adhesive acyclovir 50mg tablets are only approved for the management of recurrent oro-labial HSV-1 infections, their ability to achieve extremely high concentrations in saliva and oral t...
Read MoreA Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women
April 2018 | Volume 17 | Issue 4 | Original Article | 457 | Copyright © April 2018
Introduction: Currently, only topical minoxidil (MNX) and oral finasteride (FNS) are approved by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of and...
Read More